You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0222 B Cell Depletion Therapy in Systemic Sclerosis Associated Interstitial Lung Disease. A Multicenter, Open Label, Comparative Study with A Follow up of 94 Patient-Years

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Scleroderma, myositis and related syndromes
SAT0222 B Cell Depletion Therapy in Systemic Sclerosis Associated Interstitial Lung Disease. A Multicenter, Open Label, Comparative Study with A Follow up of 94 Patient-Years

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Melissaropoulos K, Daoussis D, Sakellaropoulos G, et al
SAT0222 B Cell Depletion Therapy in Systemic Sclerosis Associated Interstitial Lung Disease. A Multicenter, Open Label, Comparative Study with A Follow up of 94 Patient-Years
Annals of the Rheumatic Diseases 2016;75:749.